Microdosing Mushrooms: How Often Should You Take Them?

Microdosing is the practice of consuming small amounts of psychedelic substances, such as psilocybin (magic mushrooms), LSD, MDMA, and ketamine. It has gained popularity due to its perceived benefits for mental health and well-being, including improved mood, focus, and creativity. However, the legality and safety of microdosing mushrooms are questionable, and scientific research on its effectiveness is limited and inconclusive. While some individuals report positive experiences, the potential risks and long-term effects should be carefully considered.

Microdosing frequency

The standard pattern of microdosing, as suggested by Dr. Russell Newcombe (also known as Dr. Nuke), involves taking a microdose every other day for one to two weeks and then taking a break for about a week. This approach helps to prevent building a tolerance to the substance and reduces the risk of dependency. Dr. Nuke also emphasises the importance of taking breaks and carefully monitoring the effects on one's health.

Some people may choose to microdose several times a week, adjusting their dosage based on their results and preferences. This flexible approach allows individuals to find a routine that works best for them. However, it is important to note that the effects of microdosing can vary, and there is a lack of consistent research and regulation in this area.

Additionally, it is worth mentioning that microdosing psychedelics, including LSD and psilocybin ("magic mushrooms"), is illegal in many places. The legality of microdosing varies across different regions, and it is essential to be aware of the local laws and regulations before considering this practice.

While some people report positive effects on their mood, creativity, and overall well-being, the evidence regarding the effectiveness of microdosing is mixed. Some studies suggest improvements in mood and mental health, while others indicate a possible placebo effect. Therefore, it is advisable to approach microdosing with caution and consider seeking professional guidance to ensure safety and effectiveness.

Safety and effectiveness

Microdosing is a popular practice that involves taking very low, sub-hallucinogenic doses of psychedelic substances. While many people claim that microdosing offers a range of mental and physical health benefits, the evidence from recent studies is mixed, and there is limited research on the practice.

One of the main challenges in studying the safety and effectiveness of microdosing mushrooms is the variation in potency of mushrooms. Mushrooms are not regulated outside of clinical trials, so it is difficult to determine the exact dosage being administered. Additionally, the illegal status of many psychedelic substances means that there is a lack of formal regulation, making it hard for individuals to know exactly what they are consuming and its potency. This lack of regulation also carries risks, as seen in the case where at least 12 people became severely ill after consuming a product line containing mushrooms intended for microdosing.

Another challenge in assessing the safety and effectiveness of microdosing mushrooms is the individual variation in responses to psychedelic substances. People react differently to these substances, making it difficult to create a standardized approach to microdosing. Furthermore, the effects of microdosing may be influenced by the expectancy effect, where individuals experience benefits due to their expectations rather than the substance's pharmacological effects.

While there is limited research on the safety of microdosing mushrooms, some studies suggest that it is relatively safe and well-tolerated. However, there have been reports of adverse events, including physiological discomfort, increased anxiety, jitteriness, headaches, and anxiety. It is important to note that the long-term effects of microdosing may not be fully understood yet.

In terms of effectiveness, some studies have found small to medium-sized improvements in mood, mental health, and focus among individuals who microdose psilocybin mushrooms. These improvements were consistent across gender, age, and the presence of mental health concerns. However, other studies have found limited evidence of improvements in creativity, well-being, and cognitive function. The conflicting findings highlight the need for more high-quality, controlled research over a longer period and with larger participant groups to fully understand the safety and effectiveness of microdosing mushrooms.

Legality

The legality of microdosing mushrooms varies by location. Psilocybin, the psychedelic substance in "magic" mushrooms, is considered a Schedule I substance under the Controlled Substances Act (CSA) in the United States. Schedule I drugs are defined as substances with a high potential for abuse and no recognised medical use. Therefore, the use, sale, and possession of psilocybin, even in trace amounts, are illegal under federal law in the US. However, some states, like Oregon and Colorado, have passed initiatives to legalise or decriminalise the use of psilocybin for therapeutic purposes.

Similarly, in Canada, the possession and use of psilocybin mushrooms is prohibited. However, in 2023, the province of Alberta became one of the first to regulate and allow the use of psilocybin for medicinal purposes in drug-assisted psychotherapy. In the United Kingdom, psilocybin mushrooms are regulated by the Misuse of Drugs Act 1971, and in Australia, they are controlled by the Poisons Standard.

The legal status of psilocybin mushrooms is ambiguous in some jurisdictions, leading to an underground economy and social networks supporting their sale and cultivation. For example, in the US, there is ambiguity around the legal status of mushroom edibles, which may contain unregulated psychoactive substances. While Amanita muscaria mushrooms are legal to possess in most US states, the commercial production and distribution of products containing these mushrooms are not clearly addressed by existing laws.

The United Nations Convention on Psychotropic Substances, adopted in 1971, requires its members to prohibit psilocybin. However, due to pressure from the Mexican government, the mushrooms containing the drug were not specifically included in the convention. This has resulted in varying legal statuses worldwide, with some countries having different levels of regulation or prohibition.

Dosage

Microdosing typically refers to taking a small dose of psychedelic substances, including psilocybin ("magic mushrooms"), LSD, MDMA, the prescription drug Ritalin, cannabis, and ketamine. These substances are typically taken on a consistent schedule several times a week, with some people cycling on and off, microdosing for a month or two, and then taking a break.

There is no single, clearly recognized definition of a microdose for any psychedelic drug, which complicates attempts to perform consistent research. However, one definition is approximately 1/5 to 1/20 of a recreational dose. For example, a medium-strength dose of psilocybin is 2 to 3 grams of dried mushrooms, and a microdose is typically around 0.3 grams or 1 to 2 milligrams. For LSD, a typical hallucinogenic dose might be 100 to 200 mcg, while a microdose would be about 5 to 20 mcg.

It is important to note that the potency of mushrooms can vary greatly, as they are not regulated outside of clinical trials, so determining an exact dosage can be challenging. Additionally, people react to these substances differently, making it difficult to create a standardized dosage.

The standard pattern for microdosing, according to Dr. Russell Newcombe (also known as Dr. Nuke), a researcher in the field, is to take a microdose every other day for one to two weeks and then take a week off. This helps to avoid building a tolerance and because microdosing every day can be expensive. Dr. Nuke also emphasizes the importance of taking breaks from microdosing and carefully monitoring its effects on one's health.

While some people report positive effects from microdosing mushrooms, such as improved mood, reduced anxiety, and enhanced productivity, there is limited scientific evidence to support these claims. The benefits may be due to the placebo effect, and more research is needed to understand the effectiveness and safety of microdosing mushrooms.

Benefits and side effects

Microdosing refers to taking a fraction of a regular dose of a substance. Many people believe that microdosing can enhance their mood, creativity, concentration, productivity, and ability to empathize with others. However, the evidence from recent studies is mixed, and there isn't much high-quality scientific evidence supporting the effectiveness of microdosing.

Benefits

Microdosing has become a popular concept, with many people believing it can improve their mental and physical health. Some of the purported benefits of microdosing mushrooms include:

• Enhancing mood, creativity, concentration, and productivity
• Improving mental health and relieving anxiety and depression
• Boosting energy levels and enhancing focus
• Relieving physical ailments and enhancing feelings of well-being

Side Effects

While microdosing is said to bypass the more extreme effects of psychedelics, such as hallucinations and disorientation, it is important to note that it can still have side effects. Some potential side effects of microdosing mushrooms include:

• Unwanted experiences, such as increased neuroticism or a tendency to experience unwanted emotions
• Jitteriness, headaches, or anxiety
• Nausea, vomiting, seizures, and loss of consciousness if accidentally taking a larger dose than intended

It is important to note that the potency of mushrooms can vary greatly, and they are not regulated outside of clinical trials. Therefore, microdosing mushrooms is not an exact science, and it is recommended to speak with a healthcare professional before trying it. Additionally, most substances used in microdosing are illegal in many areas, which further complicates the ability to conduct consistent research.

Frequently asked questions